Company Overview of 4-Antibody AG
4-Antibody AG develops antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. The company was founded in 2002 and is based in Basel, Switzerland.As of February 12, 2014, 4-Antibody AG operates as a subsidiary of Agenus Inc.
Founded in 2002
41 61 633 22 60
41 61 633 22 61
Key Executives for 4-Antibody AG
4-Antibody AG Key Developments
Similar Private Companies By Industry
|Memo Therapeutics AG||Europe|
|SpinX Technologies SA||Europe|
|MAST Biosurgery AG||Europe|
|Basilea Pharmaceutica International Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact 4-Antibody AG, please visit www.agenusbio.com/contact/4-antibody.php. Company data is provided by Capital IQ. Please use this form to report any data issues.